Auxilius alternatives
Auxilius is a clinical trial financial management platform for R&D accrual and forecast automation, used by emerging biotechs through large pharma. The main alternatives are Condor (another clinical-finance specialist), Exigyn (a whole-company biotech FP&A platform that includes clinical accruals), Oracle ClearTrial (clinical operations planning), and spreadsheets. Choose Auxilius if R&D accruals, close and audit support are the core need and you value a specialist with SOC reports and a service team; choose Exigyn if the accrual also has to drive headcount, the three statements and cash runway in one model.
What Auxilius is built for
From Auxilius's own description: R&D accruals and close, forecasting, investigator spend and vendor management, with controls supporting SOX 404(a) and 404(b) filers. It reports SOC 1 Type 2 and SOC 2 Type 2 compliance, single-tenant environments and exportable audit history, and joined the Veeva Product Partner Program in 2026 with a Veeva EDC integration. It says it serves more than 100 biopharma companies.
Auxilius vs Exigyn
| Auxilius | Exigyn | |
|---|---|---|
| Core job | Clinical trial financial management: R&D accruals, close, forecasting | Whole-company biotech plan: clinical, headcount, OpEx, statements, runway |
| Clinical trial accruals | Yes, with audit controls for SOX filers | Yes, driven by enrollment, SOA and CRO grids; amendments versioned |
| Data ingestion | Veeva EDC integration; clinical and vendor data | File imports (CRO grids, site budgets, EDC exports, invoices), QuickBooks Online and NetSuite sync, MCP |
| Headcount and workforce planning | Outside scope | Yes, including milestone-gated hiring |
| Three statements and BvA | Outside scope | Yes |
| Cash runway and scenarios | Clinical forecast | Company-wide runway, milestones, financing events, probabilistic simulation |
| AI | AI and agentic clinical finance features | AI agents across all modules, in the app, Excel and Claude/ChatGPT/Gemini via MCP; writes can require human approval |
| Security attestations | SOC 1 Type 2, SOC 2 Type 2, single-tenant | Runs on SOC 2 Type II–audited providers; org-level row isolation; no own attestation yet |
| Pricing | On request | Public: $500 or $1,500 per month, free 14-day sandbox |
When Auxilius is the better choice
- You are a public company (or preparing to be) and the accrual's SOX controls are the priority.
- Auditors or procurement require the vendor's own SOC 1 and SOC 2 reports, or a single-tenant environment.
- Your trials run on Veeva EDC and you want a native integration.
- You want a specialist team working alongside your accounting staff.
When Exigyn is the better choice
- The clinical accrual is one input into a company-wide plan you also need to build: headcount, OpEx, CapEx, statements, runway.
- You want scenario answers (slipped readout, paused program, RIF) the same day.
- You want to evaluate on a sample company now, at a published price, without a sales cycle.
- Your team wants AI agents to operate the plan from Excel, Claude or ChatGPT under approval.
Other alternatives
- Condor: AI platform for biopharma R&D finance and clinical operations with CTMS, EDC, ERP and IRT integrations; SOC 1 Type 2 and SOC 2 Type 2. Condor alternatives →
- Oracle ClearTrial: study cost planning and benchmarking for clinical operations at larger companies.
- Spreadsheets: still right for one study with one CRO.
- Generic FP&A (Vena, Adaptive, Jirav): company-wide planning, with clinical logic built by your team.
Compare all biotech FP&A options → · Try Exigyn on a sample biotech →
FAQ
Is Exigyn a replacement for Auxilius?
For companies that need clinical accruals plus the company-wide plan, yes. For public companies whose priority is SOX-grade accrual controls with a specialist service team, Auxilius is purpose-built for that.
Can Auxilius and Exigyn be used together?
Yes. Some teams keep a clinical-finance system of record for accruals and plan the company in Exigyn, importing accrual and forecast outputs as clinical spend.
Does Exigyn have SOC 2?
Exigyn runs on SOC 2 Type II–audited infrastructure (Vercel, Supabase, Clerk), isolates each organization's data with row-level security, encrypts data in transit and at rest, and stores no PHI. It does not yet hold its own SOC 2 attestation.
Exigyn ships with a preloaded sample biotech company: runway, clinical accruals, headcount and budget vs. actuals in one model. Free 14-day trial, no credit card.
